Join us as we speak to Dr. Courtney DiNardo from MD Anderson Cancer Center in Houston, TX. about the recent advancements in AML treatment. Dr. DiNardo is an academic clinical researcher who has participated in clinical trials resulting in three new AML therapies since 2017. In this episode, we dive into the new treatments that are showing great promise, as well as discuss how AML can be hereditary. With recent results of the Beat AML Master Clinical Trial, the increasing potential of immunotherapy and other new treatments, this episode is sure to give hope for current and future AML patients and caregivers.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Acute myeloid leukemia (AML)
- MD Anderson
- Beat AML® Master Clinical Trial
- Personalized Medicine
- Minimal Residual Disease
- Hereditary Hematologic Malignancy Leukemia Clinic
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Financial support
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
Support for this episode provided by Astellas and Novartis.